Candidal colonization, strain diversity, and antifungal susceptibility among adult diabetic patients
- PMID: 20220258
- PMCID: PMC2855059
- DOI: 10.4103/0256-4947.60514
Candidal colonization, strain diversity, and antifungal susceptibility among adult diabetic patients
Abstract
Background and objectives: Candidal colonization in diabetics is a matter of debate. The aim of this study is to investigate oral candidal colonization, strain diversity, antifungal susceptibility, and the influence of local and systemic host factors on candidal colonization in adult diabetics.
Methods: We conducted a case-control study that compared 150 diabetics (49 type 1, 101 type 2) with 50 healthy controls. Two salivary samples were collected, using the oral rinse sampling method: one for salivary flow rate and pH determination, and the other for candidal colonization assessment. The candidal isolates were identified and tested in vitro for antifungal susceptibility using the commercial kit, Candifast. The relationship between specific host factors and candidal colonization was also investigated.
Results: Diabetics had a higher candidal carriage rate compared to controls, but not density. Candida albicans was the most frequently isolated species, but diabetics had a variety of other candidal species present. None of the control samples were resistant to any tested antifungal, while the diabetic samples had differing resistances to azole antifungals. Although there was a significant positive correlation between glycemic control and candidal colonization in type 2 diabetics, there was a negative correlation between salivary pH and candidal carriage in the controls versus density in type 2 diabetics.
Conclusions: Diabetic patients not only had a higher candidal carriage rate, but also a variety of candidal species that were resistant to azole antifungals. Oral candidal colonization was significantly associated with glycemic control, type of diabetes, and salivary pH.
Figures
Similar articles
-
Detection of species diversity in oral candida colonization and anti-fungal susceptibility among non-oral habit adult diabetic patients.J Nat Sci Biol Med. 2014 Jan;5(1):148-54. doi: 10.4103/0976-9668.127315. J Nat Sci Biol Med. 2014. PMID: 24678215 Free PMC article.
-
Prevalence of oral Candida colonization in patients with diabetes mellitus.J Mycol Med. 2016 Jun;26(2):103-110. doi: 10.1016/j.mycmed.2015.12.008. Epub 2016 Feb 12. J Mycol Med. 2016. PMID: 26879707
-
In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus.Oral Microbiol Immunol. 2006 Jun;21(3):177-82. doi: 10.1111/j.1399-302X.2006.00274.x. Oral Microbiol Immunol. 2006. PMID: 16626375
-
Mixed salivary glucose levels and candidal carriage in patients with diabetes mellitus.J Oral Pathol Med. 1991 Jul;20(6):280-3. doi: 10.1111/j.1600-0714.1991.tb00928.x. J Oral Pathol Med. 1991. PMID: 1890663 Review.
-
Oral candidosis--clinical challenges of a biofilm disease.Crit Rev Microbiol. 2011 Nov;37(4):328-36. doi: 10.3109/1040841X.2011.585606. Epub 2011 Jul 21. Crit Rev Microbiol. 2011. PMID: 21777047 Review.
Cited by
-
An alarming rise of non-albicans Candida species and uncommon yeasts in the clinical samples; a combination of various molecular techniques for identification of etiologic agents.BMC Res Notes. 2019 Nov 29;12(1):779. doi: 10.1186/s13104-019-4811-1. BMC Res Notes. 2019. PMID: 31783903 Free PMC article.
-
Candida Species Diversity in Oral Cavity of Type 2 Diabetic Patients and their In vitro Antifungal Susceptibility.Contemp Clin Dent. 2018 Jun;9(Suppl 1):S83-S88. doi: 10.4103/ccd.ccd_70_18. Contemp Clin Dent. 2018. PMID: 29962770 Free PMC article.
-
Oropharyngeal Candida Colonization in Patients with Acute Myeloid Leukemia.Front Dent. 2020 Mar;17(6):1-6. doi: 10.18502/fid.v17i1.3966. Epub 2020 Mar 20. Front Dent. 2020. PMID: 33615304 Free PMC article.
-
Subgingival areas as potential reservoirs of different Candida spp in type 2 diabetes patients and healthy subjects.PLoS One. 2019 Jan 10;14(1):e0210527. doi: 10.1371/journal.pone.0210527. eCollection 2019. PLoS One. 2019. PMID: 30629672 Free PMC article.
-
Mannan-binding lectin inhibits Candida albicans-induced cellular responses in PMA-activated THP-1 cells through Toll-like receptor 2 and Toll-like receptor 4.PLoS One. 2013 Dec 31;8(12):e83517. doi: 10.1371/journal.pone.0083517. eCollection 2013. PLoS One. 2013. PMID: 24391778 Free PMC article.
References
-
- Rossie K, Guggenheimer J. Oral candidiasis: Clinical manifestations, diagnosis, and treatment. Pract Periodont Aesthet Dent. 1997;9:635–41. - PubMed
-
- Willis AM, Coulter WA, Fulton CR, Hayes JR, Bell PM, Lamey PJ. Oral candidal carriage and infection in insulin-treated diabetic patients. Diabet Med. 1999;16:675–9. - PubMed
-
- Kumar BV, Padshetty NS, Bai KY, Rao MS. Prevalence of Candida in the oral cavity of diabetic subjects. J Assoc Physicians India. 2005;53:599–602. - PubMed
-
- Soysa NS, Samaranayake LP, Ellepola AN. Diabetes mellitus as a contributory factor in oral candidosis. Diabet Med. 2006;23:455–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical